https://nsc76751inhibitor.com
Permanent pacemaker implantation (PPMI) rates following transcatheter aortic valve implantation (TAVI) demonstrate a variability, ranging from 34% to 259%. The prognosis for individuals with PPMI is typically more severe. Surgical placement of the valve at a lower depth is likely to heighten the risk of electrical conduction impairments. The theoretical capacity of cusp-overlap projection (COP) is to permit a more advanced valve deployment. The study examines the rate of PPMI within 30 days of TAVI procedures employing self-expanding valves under fluorosco
Like
Comment
Share
